Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis

Hepatocellular carcinoma (HCC) is a primary cause of cancer-related death in the world. Despite the fact that there are many methods to treat HCC, the 5-year survival rate of HCC is still at a low level. Emodin can inhibit the growth of HCC cells in vitro and in vivo. However, the gene regulation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Rui-sheng, Wang, Xiong-Wen, Sun, Qin-feng, Ye, Zeng Jie, Liu, Jian-wei, Zhou, Dai-Han, Tang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545785/
https://www.ncbi.nlm.nih.gov/pubmed/31236404
http://dx.doi.org/10.1155/2019/3065818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545785/
https://www.ncbi.nlm.nih.gov/pubmed/31236404
http://dx.doi.org/10.1155/2019/3065818

Ejemplares similares